Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Human non-embryonic CD34+multipotent stem cells isolated from umbilical cord blood | Human | other | stem cell | adherent | plasmid | K2 Transfection System | publication | S. Sharma et al., Cell Biol. Int., 2016, 40: 1366-1371, doi: 10.1002/cbin.10681 | |||||
Human fetal cortical stem cell cultures | Human | brain | stem cell | adherent | plasmid | Metafectene | publication | S. Couillard-Despres et al., 2014, US 8,841,430 | Link | ||||
3AB-OS |
Human osteocarsoma cancer stem cell line | Human | unknown | stem cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | R. di Tiore et al., Bone, 2014, 60: 198-212, doi.org/10.1016/j.bone.2013.12.021 | |||
3AB-OS |
Human osteocarsoma cancer stem cell line | Human | unknown | stem cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. Marcatti, PhD Thesis, 2015, University of Palermo | Link | ||
ASC |
Human adipose derived stem cells | Human | other | stem cell | adherent | plasmid | Metafectene PRO | publication | J. Grillari et al., 2015, Patent US9212362B2 | Link | |||
GSC-1 |
Human glioblastoma stem-like cells | Human | brain | stem cell | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. B. Morelli et al., Int. J. of Cancer, 2012, 131: E1067–E1077, DOI: 10.1002/ijc.27588 | Link | ||
GSC-1 |
Human glioma stem-like cells | Human | brain | stem cell | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. Nabissi et al., Int. J. Cancer, 2015, 137: 1855-1869 | Link | ||
GSC-30 |
Human glioma stem-like cells | Human | brain | stem cell | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. Nabissi et al., Int. J. Cancer, 2015, 137: 1855-1869 | Link | ||
GSC-30 |
Human glioblastoma stem-like cells | Human | brain | stem cell | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. B. Morelli et al., Int. J. of Cancer, 2012, 131: E1067–E1077, DOI: 10.1002/ijc.27588 | Link | ||
GSC-83 |
Human glioma stem-like cells | Human | brain | stem cell | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. Nabissi et al., Int. J. Cancer, 2015, 137: 1855-1869 | Link | ||
GSC-83 |
Human glioblastoma stem-like cells | Human | brain | stem cell | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. B. Morelli et al., Int. J. of Cancer, 2012, 131: E1067–E1077, DOI: 10.1002/ijc.27588 | Link | ||
hADSC |
Human primary adipose-derived stem cells | Human | other | stem cell | adherent | plasmid | K2 Transfection System | application note | ![]() |
||||
hBCSCs |
Human breast cancer stem cells (from xenografts of human breast cancers) | Human | respiratory system | stem cell | adherent | siRNA | RNA-Interference | Metafectene SI | publication | W.-W. Chang et al., Breast Cancer Res., 2013, 15: R39, doi:10.1186/bcr3423 | Link | ||
hBMSC |
Human bone marrow-derived mesenchymal stem cells | Human | bone | stem cell | adherent | plasmid | Metafectene | publication | D. Malik et al., PLoSONE, 13(9):e0203614, doi.org/10.1371/journal.pone.0203614 | Link | |||
hBMSC |
Human bone marrow-derived mesenchymal stem cells | Human | bone | stem cell | adherent | siRNA | Metafectene PRO | publication | E. J. Lee, Mol. Therapy, 2018, doi: 10.1016/j.ymthe.2017.12.015 | ||||
hESC |
Human embryonic stem cells | Human | unknown | stem cell | adherent | plasmid | Metafectene PRO | publication | J. Suchánková et al., Europ. J. of Histochemistry, 2014; 58:2389, doi:10.4081/ejh.2014.2389 | Link | |||
hHSC |
Human hematopoietic stem cells (CD34+) | Human | immune system | stem cell | suspension | plasmid | K2 Transfection System | application note | ![]() |
||||
hMSC |
Human primary mesenchymal stem cells | Human | unknown | stem cell | adherent | plasmid | K2 Transfection System | application note | ![]() |
||||
hMSC |
Human primary mesenchymal stem cells | Human | unknown | stem cell | adherent | plasmid | RNA-Interference | Metafectene | publication | J. Cheng et al., Wei Sheng Yan Jiu, Sep 2006; 35(5): 564-6. | |||
hMSC |
Human primary mesenchymal stem cells | Human | unknown | stem cell | adherent | plasmid | K2 Transfection System | application note | ![]() |
||||
hMSC |
Human mesenchymal stem cells | Human | unknown | stem cell | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | E. A. Ostrakhovitch et al., Exp. Cell Res., 2019, 385: 111683, doi.org/10.1016/j.yexcr.2019.111683 | Link | ||
hTMSC |
Tonsil-Derived Mesenchymal Stem Cells | Human | other | stem cell | adherent | siRNA | RNA-Interference | Metafectene | publication | Y. Lee et al., Cells, 2019, 8, 368, doi:10.3390/cells8040368 | Link | ||
hUCB-MSC |
Human umbilical cord blood derived mesenchymal stem cells | Human | other | stem cell | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | E. J. Lee et al., Molecular Therapy: Methods & Clinical Development, 2019, 13, doi.org/10.1016/j.omtm.2019.05.003 | Link | |||
NT2D1 |
Human malignant pluripotent embryonal carcinoma stem cell line | ATCC CRL-1973 | Human | genital tract | stem cell | adherent | plasmid | Metafectene | publication | L. Sessa et al., RNA, Feb 2007; 13: 223 - 239 | Link | ||
NTERA2 |
Human malignant pluripotent embryonal carcinoma stem cell line | ATCC CRL-1973 | Human | genital tract | stem cell | adherent | plasmid | Metafectene PRO | application note | ![]() |